Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Multicenter Cross-sectional Study of Patients With Uncontrolled Severe Asthma in the Population of the Russian Federation

NCT06472310 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06472310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06472310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Multicenter Cross-sectional Study of Patients With Uncontrolled Severe Asthma in the Population of the Russian Federation
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Recruiting
Start date
June 6, 2024
Completion date
June 30, 2027
Enrollment
5,000 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

severe asthma